Monika Targońska

Mrs. Monika Targońska

Medical University of Gdansk, Department of Biology and Genetics
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JJJacek Jasiecki
Jacek Jasiecki
MTMonika Targońska
Monika Targońska
BWBartosz Wasag
Bartosz Wasag
Alzheimer’s disease (AD), the most common form of dementia in elderly individuals, is marked by progressive neuron loss. Despite more than 100 years of research on AD, there is still no treatment to cure or prevent the disease. High levels of amyloid-β (Aβ) plaques and neurofibrillary tangles (NFTs) in the brain are neuropathological hallmarks of AD. However, based on postmortem analyses, up to 44% of individuals have been shown to have high Aβ deposits with no clinical signs, due to having a “cognitive reserve”. The biochemical mechanism explaining the prevention of cognitive impairment in the presence of Aβ plaques is still unknown. It seems that in addition to protein aggregation, neuroinflammatory changes associated with aging are present in AD brains that are correlated with a higher level of brain iron and oxidative stress. It has been shown that iron accumulates around amyloid plaques in AD mouse models and postmortem brain tissues of AD patients. Iron is required for essential brain functions, including oxidative metabolism, myelination, and neurotransmitter synthesis. However, an imbalance in brain iron homeostasis caused by aging underlies many neurodegenerative diseases. It has been proposed that high iron levels trigger an avalanche of events that push the progress of the disease, accelerating cognitive decline. Patients with increased amyloid plaques and iron are highly likely to develop dementia. Our observations indicate that the butyrylcholinesterase (BChE) level seems to be iron-dependent, and reports show that BChE produced by reactive astrocytes can make cognitive functions worse by accelerating the decay of acetylcholine in aging brains. Why, even when there is a genetic risk, do symptoms of the disease appear after many years? Here, we discuss the relationship between genetic factors, age-dependent iron tissue accumulation, and inflammation, focusing on AD.

Verified
Journal Article
Open access
PDF file
JJJacek Jasiecki
Jacek Jasiecki
MTMonika Targońska
Monika Targońska
AJAnna Janaszak-Jasiecka
Anna Janaszak-Jasiecka
MCMagdalena Chmara
Magdalena Chmara
MŻMonika Żuk
Monika Żuk
BWBartosz Wasag
Bartosz Wasag
Familial hypercholesterolemia (FH) is an autosomal-dominant disorder caused mainly by substitutions in the low-density lipoprotein receptor (LDLR) gene, leading to an increased risk of premature cardiovascular diseases. Tremendous advances in sequencing techniques have resulted in the discovery of more than 3000 variants of the LDLR gene, but not all of them are clinically relevant. Therefore, functional studies of selected variants are needed for their proper classification. Here, a single-cell, kinetic, fluorescent LDL uptake assay was applied for the functional analysis of LDLR variants in a model of an LDLR-deficient human cell line. An LDLR-defective HEK293T cell line was established via a CRISPR/Cas9-mediated luciferase–puromycin knock-in. The expressing vector with the LDLR gene under the control of the regulated promoter and with a reporter gene has been designed to overproduce LDLR variants in the host cell. Moreover, an LDLR promoter–luciferase knock-in reporter system has been created in the human cell line to study transcriptional regulation of the LDLR gene, which can serve as a simple tool for screening and testing new HMG CoA reductase-inhibiting drugs for atherosclerosis therapy. The data presented here demonstrate that the obtained LDLR-deficient human cell line HEK293T-ldlrG1 and the dedicated pTetRedLDLRwt expression vector are valuable tools for studying LDL internalization and functional analysis of LDLR and its genetic variants. Using appropriate equipment, LDL uptake to a single cell can be measured in real time. Moreover, the luciferase gene knock-in downstream of the LDLR promotor allows the study of promoter regulation in response to diverse conditions or drugs. An analysis of four known LDLR variants previously classified as pathogenic and benign was performed to validate the LDLR-expressing system described herein with the dedicated LDLR-deficient human cell line, HEK293T-ldlrG1.

20 November 2025 in Atherosclerosis Plus
Verified
Journal Article
Open access
MTMonika Targońska
Monika Targońska
AJAnna Janaszak-Jasiecka
Anna Janaszak-Jasiecka
MCMagdalena Chmara
Magdalena Chmara
MŻMonika Żuk
Monika Żuk
Leszek KalinowskiLeszek Kalinowski
Leszek Kalinowski
BWBartosz Wasag
Bartosz Wasag
Familial hypercholesterolemia is a genetic disorder caused by pathogenic or likely pathogenic variants in four key genes: LDLR, APOB, PCSK9, and APOE. It leads to elevated levels of low-density lipoprotein cholesterol in the bloodstream and significantly increases the risk of coronary artery disease. This study aimed to functionally characterize LDLR variants identified in Polish FH patients. Experimental data were used to learn about variants' phenotypes and incorporate them into the ACMG/AMP variant classification framework. The functional analysis was performed using the HEK293T-ldlrG1 cells with the expression vectors pTetRedLDLR carrying the mutated LDLR gene variants. Receptor expression was evaluated using Western blot and immunofluorescence. The low-density lipoprotein uptake and ligand binding capacity were examined with fluorescent dye-labeled LDL by confocal microscopy. A functional study was performed to analyze the variants under assessment and compare them to known benign and pathogenic control variants. The experimental study revealed an impaired activity of the c.662A > G p. (Asp221Gly), c.1775G > A p. (Gly592Glu), and c.2483delA p. (Tyr828Phefs∗101) LDLR variants, classifying them as functionally abnormal. In contrast, in vitro activity assessment of the c.91G > A p. (Glu31Lys) LDLR variant showed fully functional low-density lipoprotein binding and uptake activities. These results suggested that c.91G > A p. (Glu31Lys) is unlikely to be a disease-causing variant. The results provide functional evidence for the activity of selected LDLR variants in a cellular model based on confocal techniques that meets the ACMG/AMP variant classification criteria. These findings highlight the importance of in vitro assays in evaluating the functional impact of LDLR variants and contribute valuable insights for clinical interpretation and genetic counseling.

16 April 2026 in Chemico-Biological Interactions
Verified
Journal Article
Open access
MLMateusz Leśniewski
Mateusz Leśniewski
RDRafał Dutkiewicz
Rafał Dutkiewicz
MTMonika Targońska
Monika Targońska
KWKrzysztof Waleron
Krzysztof Waleron
BWBartosz Wasąg
Bartosz Wasąg
JJJacek Jasiecki
Jacek Jasiecki
Structural characterization of proteins is essential for understanding their function, stability, and role in disease. Butyrylcholinesterase (BChE), expressed in the brain and localized within amyloid-β plaques, may generate an extended 69-amino acid, cysteine-rich signal peptide capable of self-aggregation and iron binding. In this study, we investigated the structure and aggregation of the BChE signal peptide using far-UV circular dichroism (CD) spectroscopy combined with in silico modelling via AlphaFold and coarse-grained replica-exchange molecular dynamics simulations with the UNRES force field. CD spectra revealed a predominance of β-sheet structure, with additional α-helices and statistical coil contributions. These experimental results were qualitatively consistent with AlphaFold and UNRES predictions, which revealed mixed α and β secondary structure in oligomeric assemblies. UNRES also predicted a substantial statistical coil content. Thermal CD analyses revealed marked differences in stability between variants. The p.C31Y signal peptide showed no significant spectral changes after heating, indicating exceptional resistance to thermal unfolding. In contrast, the wild-type peptide exhibited partial structural change under identical conditions. To refine structural interpretation, three short fragments of the BChE signal sequence (P1-P3) were analyzed by far-UV CD. P1 and P3 were largely disordered, whereas P2 displayed mixed secondary structure. An equimolar mixture of all three fragments produced an approximately additive CD spectrum, suggesting minimal conformational interference. Notably, P1 and P2 improved the solubility of the hydrophobic P3 fragment. Overall, these findings support a stable, aggregation-prone architecture for the extended BChE signal peptide and provide molecular insights into its potential role in promoting Alzheimer's pathology.